Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-09-28

FDA Approved: LEVETIRACETAM — Original Application (Hisun Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved Hisun Pharmaceuticals USA, Inc.'s original application for a generic levetiracetam product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEVETIRACETAM (levetiracetam)

Snippet

ORIG AP for LEVETIRACETAM (LEVETIRACETAM)